CTDiscover the employees benefits and perks available to Candel Therapeutics employees.
Learn about the 3 benefits and perks Candel Therapeutics offers its employees.
Career development opportunities
Flexible work arrangements offered
100% remote work options available for certain roles
CT51-200 employees
1999
Paul Peter Tak
Try our AI resume builder, interview practice, and cover letter generator for free. Then, unlock unlimited use for just $9/month.
View all toolsExplore the variety of open remote roles at Candel Therapeutics, offering flexible work options across multiple disciplines and skill levels.
Find your next opportunity by exploring profiles of companies that are similar to Candel Therapeutics. Compare culture, benefits, and job openings on Himalayas.
Sign up now and join over 100,000 remote workers who receive personalized job alerts, curated job matches, and more for free!
Sign up now and join over 100,000 remote workers who receive personalized job alerts, curated job matches, and more for free!
Join the remote work revolution
Join over 100,000 job seekers who get tailored alerts and access to top recruiters.
CT
United States onlyEmployee count: 51-200
Salary: 175k-190k USD
CTUnited States onlyEmployee count: 51-200
Salary: 166k-180k USD
CB
EX
LBFind your next opportunity by exploring profiles of companies that are similar to Candel Therapeutics. Compare culture, benefits, and job openings on Himalayas.
Coherus BioSciences is a commercial-stage biopharmaceutical company focused on the research, development, and commercialization of innovative immunotherapies to treat cancer.
Exelixis, Inc. is a biotechnology company focused on innovative cancer treatments, driven by a commitment to patient care and research excellence.
Legend Biotech is a commercial-stage biotechnology firm specializing in the development of innovative therapies for cancer treatment.
Arcellx, Inc. is a biotechnology company focused on developing innovative cell therapies for cancer treatment, with a commitment to making therapies safer and more accessible.
Dendreon is dedicated to personalized cancer treatment and has made significant advancements with its FDA-approved immunotherapy, Provenge.
Replimune is focused on developing innovative oncolytic immunotherapies aimed at treating difficult-to-treat cancers by harnessing the immune system.
